Researchers Identify Molecule That Triggers Smoking-Related Lung Disease

by Aruna on  April 27, 2009 at 4:20 PM Respiratory Disease News   - G J E 4
Researchers Identify Molecule That Triggers Smoking-Related Lung Disease
A molecule which contributes to the development of smoking-related lung disease has been identified by researchers.

Long-term exposure to compounds found in smoke can lead to both cardiovascular and lung disease.

Although lung exposure to cigarette smoke leads to immune cell recruitment and tissue fibrosis, how cigarette smoke causes these changes is unknown.

The researchers sought to determine if osteopontin, a molecule that attracts immune cells, mediates cell recruitment in smokers.

Prasse et al compared osteopontin levels from smokers with different types of lung diseases, healthy smokers, and healthy non-smokers.

They found high levels of osteopontin expression in patients with interstitial lung disease, whereas healthy smokers had lower levels, and healthy non-smokers produced no osteopontin.

Moreover, expressing osteopontin in rat lung resulted in recruitment of immune cells, resulting in symptoms similar to smoking-related interstitial lung diseases. These results indicate that osteopontin may be pathogenic in smoking-initiated lung disease.

The researchers said " that chronic nicotine stimulation induced by cigarette smoking promotes macrophage and Langerhans cell accumulation in the lung via an increase in [osteopontin production]."

Osteopontin and cellular receptors for nicotine may therefore be new targets for treating smoking related lung disease.

The study appears in The American Journal of Pathology.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like